Open Access Article
Yanlong Luo,
Huaming Sun*,
Weiqiang Zhang,
Xiu Wang,
Shan Xu,
Guofang Zhang,
Yajun Jian and
Ziwei Gao
*
Key Laboratory of Applied Surface and Colloid Chemistry, MOE School of Chemistry and Chemical Engineering, Shaanxi Normal University, Xi'an 710062, P. R. China. E-mail: hmsun@snnu.edu.cn; zwgao@snnu.edu.cn
First published on 31st May 2017
A new triple cooperative and relay catalysis system featuring the Mannich addition followed by C–C construction and oxydehydrogenation is described. The zirconocene dichloride and trimellitic acid synergic catalysis triggered the Mannich addition and C–C bond construction reactions, while CuO allowed relay catalysis for oxydehydrogenation. This novel strategy demonstrated superior activity for the synthesis of substituted quinolines from commercially available anilines, aldehydes and ketones. The corresponding substituted quinolines were synthesized with 32 examples in 90–96% yields under mild reaction conditions. A novel zirconocene–Brønsted acid complex, generated in situ and acting as an active catalyst, was validated from the mechanistic studies.
The cascade reactions for the Mannich reaction followed by the C–C or C–N bond formation are of highly appealing (Scheme 1). This is because such kind of reactions could construct these fundamental bonds of organic molecules in a single step. In literature, two divergent synthetic procedures with such cascade reaction were available. In 2010, Shin13 discovered an one pot redox-pinacol-Mannich–Michael cascade reaction leading to the synthesis of 1-aminoindanes and 5,6-fused azacycles (Scheme 1, eq. a). In this reaction, the gold catalyst rendered the Mannich reaction followed by C–N formation in an intramolecular manner. Very recently, HCl,14 iodine,15 CuCl2,16 FeCl3 (ref. 17) and AgOTf18 catalyzed three components tandem reactions of anilines, aldehydes and ketones for the construction of multi-functionalized quinoline had been reported (Scheme 1, eq. b). This approach undergone intermolecular Mannich reaction followed by intramolecular C–C bond formation and oxydehydrogenation.
In this paper, combination with the advantages of cascade reaction integrating the Mannich addition and C–C/C–N bond construction, the development of new catalytic systems is highly desirable in organic synthesis. Herein, we report an unprecedented cooperative and relay catalysis by zirconocene dichloride, trimellitic acid and CuO triple catalytic system for the Mannich addition/C–C bond formation/oxydehydrogenation sequence (Scheme 1, eq. c). This triple cooperative and relay catalytic system demonstrated superior activity for synthesis of polysubstituted quinoline from arylamines, aldehydes and ketones under mild condition.
:
1) at 60 °C.
| Entry | Catalyst | Brønsted acid | Yieldb (%) |
|---|---|---|---|
| a All reactions were conducted using the aniline (1.0 mmol), benzaldehyde (1.0 mmol), methyl pyruvate (1.0 mmol), catalyst (0.05 mmol, 5 mol%), Brønsted acid (0.05 mmol, 5 mol%), 50 °C, 1 h.b Isolated yields.c 50 °C, 2 h. | |||
| 1 | Cp2TiCl2/CuCl2 | PhCOOH | 30 |
| 2 | Cp2TiCl2/CuBr2 | PhCOOH | 28 |
| 3 | Cp2TiCl2/Cu(acac)2 | PhCOOH | 25 |
| 4 | Cp2TiCl2/Cu(OAc)2 | PhCOOH | 22 |
| 5 | Cp2TiCl2/CuSO4·5H2O | PhCOOH | 24 |
| 6 | Cp2TiCl2/CuO | PhCOOH | 31 |
| 7 | Cp2TiCl2/Cu(OTf)2 | PhCOOH | 26 |
| 8 | Cp2TiCl2/Cu(ClO4)2 | PhCOOH | 27 |
| 9 | Cp*TiCl3/CuO | PhCOOH | 29 |
| 10 | Cp2ZrCl2/CuO | PhCOOH | 34 |
| 11 | Cp2ZrCl2/CuO | PhOH | 20 |
| 12 | Cp2ZrCl2/CuO | PhSO3H | 26 |
| 13 | Cp2ZrCl2/CuO | Ph (COOH)NH2 | 41 |
| 14 | Cp2ZrCl2/CuO | Ph (COOH)OH | 42 |
| 15 | Cp2ZrCl2/CuO | Ph (COOH)2 | 47 |
| 16 | Cp2ZrCl2/CuO | (CH2)3(COOH)2 | 29 |
| 17 | Cp2ZrCl2/CuO | HNC4H7COOH | 28 |
| 18 | Cp2ZrCl2/CuO | H2NPh (SO3H)2 | 45 |
| 19 | Cp2ZrCl2/CuO | 5-SO3HPhCOOH (OH) | 48 |
| 20 | Cp2ZrCl2/CuO | Ph (COOH)3 | 54 |
| 21 | Cp2ZrCl2/CuO | Ph (COOH)3 | 88c |
With the optimal reaction conditions in hand, we set out to expand the generality and scope of Cp2ZrCl2, trimellitic acid and CuO catalyzed three-component cascade reaction. 1 mmol aldehyde, 1.1 mmol of anilines and 1.5 mmol of ketones with 5 mol% of Cp2ZrCl2, 5 mol% of trimellitic acid, 5 mol% of CuO at 60 °C for 2 h were operated as the typical selection. It is found that the reaction proceeded smoothly with aldehydes and aromatic amines bearing either electron-withdrawing or donating groups (Table 2). The substituents with different electron properties has little impact on this transformation, such as anilines containing methyl (4ab), methoxyl (4ac) or fluorous (4ai) group, benzaldehydes with methyl (4ak), i-propyl (4al), t-butyl (4am) or methoxyl (4ad) group and pyruvate with methyl or ethyl group. Aniline with methyl (4ab) and methoxyl (4ac) substituents led to the excellent results (90–91%), when benzaldehyde and methyl pyruvate were used. The p-substituents of anilines were changed from methyl (4ae), i-propyl (4af), t-butyl (4ag) to methoxyl (4ah) reacted with 4-methoxybenzaldehyde and methyl pyruvate, the yields of the condensation reaction were 93–95%. Under the similar condition, treating 4-fluroaniline and benzaldehyde with methyl pyruvate afforded the substituted quinoline (4ai) in 90% yield. Benzaldehydes with methoxyl (4aj), methyl (4ak), i-propyl (4al) or t-butyl (4am) substituents obtained 92–94% yields when they reacted with 1-naphthylamine and methyl pyruvate, which provided a convenient route for the construction of tricyclic–quinolines. Aliphatic aldehydes such as cyclohexanecarbaldehyde was also readily introduced into this reaction, reacted with 1-naphthylamine or 4-methoxy aniline and methyl pyruvate afforded the desired products (4an, 4ao) in 91% and 90% yields, respectively. Heterocyclic furfuraldehyde afforded the desired product in 91% yield (4ap). 1-Naphthaldehyde reacted with aniline and methyl pyruvate or ethyl pyruvate under standard conditions afforded the multiply substituted quinolines in 92% and 91% yield (4aq and 4ar). As expected, m-substituted aniline and aldehyde (4as) produced desired quinoline in 92% yield. Gratifyingly, the sterically hindered ortho-substituted anilines (4at) still furnished the desired product in more than 90% yield.
The zirconocene dichloride/trimellitic acid/CuO cooperative and relay catalytic system was successfully applied in the three-component coupling sequence reaction of aliphatic ketones and aromatic ketones under the optimized conditions (Table 3). The reaction results had not significantly effected by aliphatic ketones. The catalytic sequence reaction of 2-butanone with benzaldehyde and 1-naphthylamine afforded the products (4bb) in 93% yields, whereas other chain ketones including 2-pentone, 2-hexanone and 2-heptanone afforded 2,4-substituted quinolines in 91–93% yield (4bd), (4be), (4bf). Cyclic ketones such as cyclohexanone (4bg) was also readily introduced into this reaction, the desired product being formed with yield of 96%. Various halogens, such as fluorine, chlorine, bromine, iodine and electron-donating groups such as methyl were all tolerated in this reaction, afforded the products with 91–94% yields (4bh, 4bi, 4bj, 4bk and 4be). This triple cooperative and relay catalytic system were also applied in the three-component cascade reaction of aromatic ketone, such as anilines, benzaldehyde reacted with acetophenone afforded 2,4-diphenylquinoline in 90% and 91% yield(4bl and 4bm), albeit with longer reaction time (12 h). To our pleased, chain aldehyde can also be used as substrate for this reaction afforded 6-methoxy-4-ethyl-2-propylquinoline in 90% yield with 12 h(4bn). More importantly, this cooperative and relay catalytic system for synthesis of substituted quinoline could be easily scaled up and the desired disubstituted quinoline was obtained in 92% yield (Scheme 2).
To get more information about the reaction mechanism, several control experiments (Table 4) and parallel experiment (Scheme 3) were set up under the standard conditions. The three components cascade reaction of aniline, benzaldehyde and methyl pyruvate without catalyst or with 5 mol% CuO did not get the desired product at 60 °C for 2 h (Table 4, entries 1 and 2). In the presence of 5 mol% trimellitic acid, three-component sequence reaction afforded the desired quinoline in 14% yield (Table 4, entry 3). With addition of 5 mol% Cp2ZrCl2 in the reaction only obtained 17% yield of quinoline (Table 4, entry 4), which eliminated the possibility that i-propanol or water coordination with zirconocene dichloride released HCl promotes this reaction. With the assistance of 5 mol% Cp2ZrCl2 and 5 mol% trimellitic acid, the desired product was isolated in 44% yield (Table 4, entries 5). Adding 5 mol% CuO into this catalytic system, the yield of 4-methoxycarbonyl-2-phenylquinoline was up to 92% (Table 4, entry 6). It is clear that the high efficiency of the coupling sequence reaction should not be attributed to zirconocene dichloride, trimellitic acid or CuO individually. We proposed that the cooperation of zirconocene dichloride, trimellitic acid and the relay of CuO, resulted in the efficient cooperative and relay catalysis. The control experiments using 10 mol% HCl afforded the substituted quinolines in 10% yield, indicating HCl was not catalytic species (Scheme 3a). This control experiments and parallel experiment indicated that zirconocene dichloride and trimellitic acid demonstrated good compatibility with CuO in three components cascade reaction, which presented a new cooperative and relay catalysis system for synthesis of multiply substituted quinolines from anilines, aldehydes and ketones. N-Arylimines and methyl pyruvate under the standard condition also afforded the desired product in 92% yield (Scheme 3b), which indicated that the imine was firstly formed in this reaction, followed by Mannich addition and cyclization.
| Entry | CuO (mol%) | Trimellitic acid (mol%) | Cp2ZrCl2 (mol%) | Yieldb (%) |
|---|---|---|---|---|
a Reaction conditions: a mixture of aldehyde (1.0 mmol); aniline (1.1 mmol); methyl pyruvate (1.5 mmol); i-PrOH : H2O (3 : 1, 0.5 mL); all reactions were carried out at 60 °C for 2 h, ND = no detected.b Isolated yield. |
||||
| 1 | — | — | — | ND |
| 2 | 5 | — | — | ND |
| 3 | — | 5 | — | 14 |
| 4 | — | — | 5 | 17 |
| 5 | — | 5 | 5 | 44 |
| 6 | 5 | 5 | 5 | 92 |
The interaction of zirconocene dichloride and trimellitic acid in three-component coupling sequence reaction for synthesis of substituted quinolines were investigated by 1H NMR and HRMS analyses. 1H NMR experiments, which were conducted using Cp2ZrCl2 in D2O (Fig. 1), showed that no coordination occurred and only one Cp singlet of Cp2ZrCl2 at δ = 6.49 ppm (
) was detected. When adding 1 equiv. trimellitic acid, a new zirconocene complex species II formed, which resonated at δ = 6.57 ppm (
). Intensity of the Cp singlet at δ = 6.57 didn't increase as the time went on. Adding 2 equiv. aniline into this transformation, zirconocene dichloride (I) was consumed gradually in D2O and transformed to a new zirconocene species Cp2Zr(OOC)2PhCOOH (II).20 The above conclusion was also certified by HRMS analysis, corresponding to the [II + H]+ signal at m/z 428.9921 (Fig. S3–S6†). These observations clearly demonstrated that during the reaction, zirconocene dichloride readily converted into zirconocene complexes II, and presumably it was the organometallic binary acid catalyst.
![]() | ||
Fig. 1 Partial 400 MHz 1H NMR spectra (D2O) of a mixture of Cp2ZrCl2 (1.0 equiv.) and trimellitic acid (1.0 equiv.) with PhNH2 (2.0 equiv). 6.49 ppm I [Cp2ZrCl2]; 6.57 ppm II Cp2Zr(OOC)2PhCOOH. | ||
Taken 1HNMR, HRMS, control experiments and paralleled experiments together, a plausible catalytic cycle of zirconocene dichloride/trimellitic acid/CuO triple cooperative and relay catalytic system in three-component sequence reaction was illustrated in Scheme 4. Zirconocene dichloride I pre-catalyst activated by trimellitic acid and transformed to binary acid catalyst II in the presence of aniline. The incoming ketone coordinated to Zr center of II. In transition state A, enolation was accelerated as the carbonyl coordinated to oxytropic Zr and methyl formed hydrogen bond with the carboxyl oxygen of trimellitic acid. The carbon–carbon bond formation is illustrated in transition state A. The coordinated enolate then undergoes addition to the aldimine, which is activated by H+ from the other carboxyl group of trimellitic acid. This transition state show cases the cooperative nature of this binary acid catalytic system. In transition state B, the electron-rich benzene ring attacked the keto-carbonyl group to formed the intermediate dihydroquinoline. After the dihydroquinoline was released, the zirconocene catalyst II was regenerated from the transition state B by coordination of the carboxyl group again. The coordination of the dihydroquinoline and CuO may induce a combination of electron transfer and intramolecular rearrangement to give the desired product21 and Cu(0)·H2O, which should be more stable than Cu(0) due to its coordination with H2O. Active Cu(0)·H2O is facilely oxidized by oxygen in the air to restore CuO, which enters next catalytic cycle.
![]() | ||
| Scheme 4 Proposed mechanism of zirconocene dichloride/trimellitic acid/CuO cooperative and relay catalysis for synthesis of substituted quinolines. | ||
:
H2O (3
:
1) 0.5 mL. The reaction mixture was heated to 60 °C and stirred until the reaction was completed as indicated by TLC, then the reaction mixture was quenched with distilled water (5.0 mL). The aqueous phase was extracted with dichloride methane (3–5 mL), dried over Na2SO4 and concentrated in vacuo to give the crude product. The crude product was purified by flash column chromatography on neutral silica gel (ethyl acetate:petroleum ether). Full experimental details and characterization data for all quinolines product are included in the ESI.†
:
1); IR (KBr): 1728, 1593, 1346, 1250, 1203, 1149, 771, 694 cm−1; 1H NMR (400 MHz, CDCl3) δ 8.75 (d, J = 8.5 Hz, 1H), 8.41 (s, 1H), 8.22 (s, 3H), 7.77 (s, 1H), 7.63 (s, 1H), 7.55 (s, 2H), 7.50 (d, J = 7.1 Hz, 1H), 4.07 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 166.85, 156.71, 149.29, 138.81, 135.61, 130.35, 129.91, 129.74, 128.94, 127.81, 127.48, 125.43, 124.00, 120.34, 52.72. HRMS (ESI): m/z called for C17H13NO2 [M + H]+, 264.1019; found, 264.1026.
:
1); IR (KBr): 1730, 1608, 1352, 1254, 1209, 1153, 775, 698 cm−1; 1H NMR (400 MHz, CDCl3) δ 8.51 (s, 1H), 8.35 (s, 1H), 8.19 (d, J = 7.3 Hz, 2H), 8.12 (d, J = 8.6 Hz, 1H), 7.61–7.57 (m, 1H), 7.54 (s, 2H), 7.47 (s, 1H), 4.06 (s, 3H), 2.58 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 166.97, 155.72, 147.94, 138.90, 138.01, 134.81, 132.18, 129.99, 129.53, 128.90, 127.36, 124.24, 124.02, 120.23, 52.65, 22.13. HRMS (ESI): m/z called for C18H15NO2 [M + H]+, 278.1176; found, 278.1177.
:
1); IR (KBr): 1726, 1591, 1344, 1253, 1206, 1152, 774, 697 cm−1; 1H NMR (400 MHz, CDCl3) δ 8.40 (s, 1H), 8.21 (d, J = 2.7 Hz, 1H), 8.16 (d, J = 7.5 Hz, 2H), 8.10 (d, J = 9.2 Hz, 1H), 7.52 (s, 2H), 7.42 (d, J = 2.6 Hz, 2H), 4.04 (s, 3H), 3.97 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 166.91, 159.05, 154.03, 145.70, 138.92, 133.17, 131.72, 129.29, 128.88, 127.14, 125.55, 122.79, 120.69, 103.22, 55.57, 52.56. HRMS (ESI): m/z called for C17H13NO2 [M + H]+, 294.1130; found, 294.1125.
:
1); IR (KBr): 1731, 1596, 1349, 1253, 1206, 1152, 778, 698 cm−1; 1H NMR (400 MHz, CDCl3) δ 8.71 (d, J = 8.3 Hz, 1H), 8.36 (s, 1H), 8.18 (d, J = 8.9 Hz, 3H), 7.75 (d, J = 1.2 Hz, 1H), 7.59 (s, 1H), 7.06 (d, J = 8.8 Hz, 2H), 4.07 (s, 3H), 3.89 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 166.96, 161.15, 156.27, 149.28, 135.50, 131.38, 130.10, 129.83, 128.85, 127.39, 125.40, 123.67, 119.93, 114.33, 55.42, 52.70. HRMS (ESI): m/z called for C18H15NO3 [M + H]+, 294.1125; found, 294.1130.
:
1); IR (KBr): 1729, 1596, 1348, 1254, 1207, 1151, 773, 696 cm−1; 1H NMR (400 MHz, CDCl3) δ 8.48 (s, 1H), 8.32 (s, 1H), 8.16 (d, J = 8.8 Hz, 2H), 8.08 (d, J = 8.6 Hz, 1H), 7.59 (dd, J = 8.6, 1.6 Hz, 1H), 7.26 (s, 2H), 7.05 (d, J = 8.8 Hz, 2H), 4.07 (s, 3H), 3.90 (s, 3H), 2.58 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 190.81, 167.07, 160.97, 155.31, 147.91, 137.53, 134.73, 132.07, 131.98, 131.48, 129.76, 128.69, 124.22, 123.67, 119.81, 114.31, 114.28, 55.39, 52.62, 22.08. HRMS (ESI): m/z called for C19H17NO3 [M + H]+, 308.1281; found, 308.1289.
:
1); IR (KBr): 1732, 1595, 1349, 1251, 1205, 1152, 774, 698 cm−1; 1H NMR (400 MHz, CDCl3) δ 8.54 (d, J = 1.4 Hz, 1H), 8.33 (s, 1H), 8.15 (s, 3H), 7.66 (d, J = 1.8 Hz, 1H), 7.05 (d, J = 8.8 Hz, 2H), 4.07 (s, 3H), 3.89 (s, 3H), 3.14 (d, J = 13.6, 6.8 Hz, 1H), 1.37 (d, J = 6.9 Hz, 6H). 13C NMR (101 MHz, CDCl3) δ 167.11, 160.97, 155.45, 148.29, 148.21, 134.92, 131.60, 130.00, 129.50, 128.72, 123.75, 121.70, 119.84, 114.29, 55.41, 52.60, 34.56, 23.88. HRMS (ESI): m/z called for C21H21NO3 [M + H]+, 336.1594; found, 336.1589.
:
1); IR (KBr): 1733, 1596, 1349, 1252, 1205, 1143, 774, 698 cm−1; 1H NMR (400 MHz, CDCl3) δ 8.72 (d, J = 2.0 Hz, 1H), 8.34 (s, 1H), 8.15 (dd, J = 15.5, 8.8 Hz, 3H), 7.85 (dd, J = 8.9, 2.1 Hz, 1H), 7.05 (d, J = 8.8 Hz, 2H), 4.08 (s, 3H), 3.89 (s, 3H), 1.46 (s, 9H). 13C NMR (101 MHz, CDCl3) δ 167.12, 160.97, 155.62, 150.36, 147.90, 135.08, 131.62, 129.59, 128.73, 123.44, 120.40, 119.88, 114.29, 55.41, 52.61, 35.29, 31.22. HRMS (ESI): m/z called for C21H21NO3 [M + H]+, 350.1751; found, 350.1756.
:
1); IR (KBr): 1725, 1591, 1343, 1247, 1201, 1146, 767, 691 cm−1; 1H NMR (400 MHz, CDCl3) δ 8.38 (s, 1H), 8.20 (d, J = 2.3 Hz, 1H), 8.14 (d, J = 8.6 Hz, 2H), 8.08 (d, J = 9.2 Hz, 1H), 7.41 (d, J = 9.2 Hz, 1H), 7.05 (d, J = 8.6 Hz, 2H), 4.06 (s, 3H), 3.98 (s, 3H), 3.89 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 167.06, 160.79, 158.78, 153.78, 145.70, 133.23, 131.59, 131.52, 128.47, 125.15, 122.65, 120.32, 114.28, 103.32, 55.57, 55.40, 52.55. HRMS (ESI): m/z called for C19H17NO4 [M + H]+, 324.1230; found, 324.1234.
:
1); IR (KBr): 1723, 1585, 1342, 1245, 1200, 1144, 767, 691 cm−1; 1H NMR (400 MHz, CDCl3) δ 8.87 (d, J = 8.5 Hz, 1H), 8.57 (s, 1H), 8.43 (s, 3H), 7.92 (s, 1H), 7.89 (s, 1H), 7.74 (s, 2H), 7.70 (d, J = 7.1 Hz, 1H), 4.11 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 176.91, 164.83, 158.21, 148.78, 144.31, 140.25, 138.90, 138.60, 137.94, 138.83, 138.45, 134.39, 133.05, 129.33, 51.65. HRMS (ESI): m/z called for C17H12FNO2 [M + H]+, 282.1019; found, 282.1012.
:
1); IR (KBr): 1733, 1597, 1351, 1255, 1209, 1154, 778, 697 cm−1; 1H NMR (400 MHz, CDCl3) δ 9.48 (d, J = 7.8 Hz, 1H), 8.59 (d, J = 9.2 Hz, 1H), 8.42 (s, 1H), 8.33 (d, J = 8.6 Hz, 2H), 7.90 (d, J = 7.5 Hz, 1H), 7.85 (d, J = 9.2 Hz, 1H), 7.73 (s, 2H), 7.09 (d, J = 8.6 Hz, 2H), 4.09 (s, 3H), 3.91 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 167.19, 161.03, 154.45, 147.28, 135.39, 133.48, 131.59, 131.52, 128.69, 128.52, 127.59, 126.97, 125.14, 122.37, 122.07, 119.02, 114.25, 55.40, 52.70. HRMS (ESI): m/z called for C22H17NO3 [M + H]+, 344.1281; found, 344.1286.
:
1); IR (KBr): 1736, 1598, 1352, 1254, 1208, 1155, 778, 697 cm−1; 1H NMR (400 MHz, CDCl3) δ 9.50 (d, J = 7.8 Hz, 1H), 8.60 (d, J = 9.2 Hz, 1H), 8.45 (s, 1H), 8.27 (d, J = 7.8 Hz, 2H), 7.86 (d, J = 9.2 Hz, 2H), 7.74 (s, 2H), 7.38 (d, J = 7.7 Hz, 2H), 4.09 (s, 3H), 2.47 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 167.22, 154.89, 147.37, 139.75, 136.16, 135.51, 133.48, 131.66, 129.65, 128.80, 128.54, 127.61, 127.25, 127.06, 125.19, 122.36, 119.38, 52.73, 21.40. HRMS (ESI): m/z called for C22H17NO3 [M + H]+, 328.1332; found, 328.1342.
:
1); IR (KBr): 1721, 1583, 1340, 1244, 1197, 1141, 762, 683 cm−1; 1H NMR (400 MHz, CDCl3) δ 9.50 (d, J = 8.0 Hz, 1H), 8.61 (d, J = 9.2 Hz, 1H), 8.46 (s, 1H), 8.30 (d, J = 8.2 Hz, 2H), 7.91–7.83 (m, 2H), 7.77–7.68 (m, 2H), 7.45 (d, J = 8.2 Hz, 2H), 4.08 (s, 3H), 3.04 (dt, J = 13.8, 6.9 Hz, 1H), 1.36 (d, J = 7.0 Hz, 6H). 13C NMR (101 MHz, CDCl3) δ 167.20, 154.99, 150.66, 147.39, 136.64, 135.47, 133.48, 131.68, 128.80, 128.53, 127.60, 127.43, 127.04, 125.22, 122.39, 122.37, 119.50, 52.71, 34.07, 23.97. HRMS (ESI): m/z called for C24H21NO3 [M + H]+, 356.1645; found, 356.1650.
:
1); IR (KBr): 1721, 1585, 1342, 1245, 1294, 1140, 765, 685 cm−1; 1H NMR (400 MHz, CDCl3) δ 9.51 (d, J = 7.9 Hz, 1H), 8.61 (d, J = 9.2 Hz, 1H), 8.47 (s, 1H), 8.30 (d, J = 8.4 Hz, 2H), 7.88 (s, 2H), 7.78–7.71 (m, 2H), 7.62 (d, J = 8.4 Hz, 2H), 4.09 (s, 3H), 1.43 (s, 9H). 13C NMR (101 MHz, CDCl3) δ 167.22, 154.97, 152.90, 147.42, 136.24, 135.51, 133.49, 131.69, 128.82, 128.54, 127.60, 127.16, 125.90, 125.22, 122.40, 122.37, 119.54, 52.73, 34.82, 31.33. HRMS (ESI): m/z called for C25H23NO3 [M + H]+, 370.1802; found, 370.1805.
:
1); IR (KBr): 1729, 1595, 1345, 1253, 1204, 1151, 774, 698 cm−1; 1H NMR (400 MHz, CDCl3) δ 9.42 (d, J = 7.7 Hz, 1H), 8.57 (d, J = 9.2 Hz, 1H), 7.89 (s, 2H), 7.85 (d, J = 9.3 Hz, 1H), 7.71 (d, J = 1.7 Hz, 2H), 4.06 (s, 3H), 3.04 (s, 1H), 2.14 (d, J = 11.9 Hz, 2H), 1.96 (d, J = 12.9 Hz, 2H), 1.80 (d, J = 11.7 Hz, 2H), 1.53 (d, J = 12.8 Hz, 4H). 13C NMR (101 MHz, CDCl3) δ 167.41, 164.84, 135.05, 133.30, 131.54, 128.28, 127.48, 126.90, 125.07, 122.40, 120.96, 52.60, 46.99, 32.91, 26.58, 26.18. HRMS (ESI): m/z called for C21H21NO3 [M + H]+, 320.1645; found, 320.1648.
:
1); IR (KBr): 1733, 1598, 1349, 1253, 1206, 1152, 775, 697 cm−1; 1H NMR (400 MHz, CDCl3) δ 8.17 (d, J = 2.7 Hz, 1H), 7.99 (d, J = 9.2 Hz, 1H), 7.85 (s, 1H), 7.37 (dd, J = 9.2, 2.8 Hz, 1H), 4.03 (s, 3H), 3.96 (s, 3H), 2.01 (s, 1H), 1.77–1.59 (m, 4H), 1.33–1.24 (m, 4H), 1.01–0.89 (m, 2H). 13C NMR (101 MHz, CDCl3) δ 167.13, 163.49, 158.51, 145.18, 133.01, 130.96, 130.88, 125.14, 122.22, 121.43, 103.32, 55.53, 52.43, 47.08, 32.81, 26.51, 26.04. HRMS (ESI): m/z called for C18H21NO3 [M + Na]+, 322.1414; found, 322.1421.
:
1); IR (KBr): 1720, 1583, 1340, 1243, 1194, 1142, 764, 683 cm−1; 1H NMR (400 MHz, CDCl3) δ 8.35 (s, 1H), 8.20 (d, J = 2.6 Hz, 1H), 8.06 (d, J = 9.3 Hz, 1H), 7.62 (s, 1H), 7.40 (dd, J = 9.2, 2.6 Hz, 1H), 7.19 (d, J = 3.3 Hz, 1H), 6.98 (s, 1H), 4.05 (s, 3H), 3.97 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 169.16, 168.26, 166.72, 159.03, 153.30, 146.21, 145.46, 143.92, 133.20, 131.35, 125.50, 122.95, 119.44, 112.27, 109.55, 103.47, 55.59, 52.60. HRMS (ESI): m/z called for C16H13NO4 [M + H]+, 284.0917; found, 284.0922.
:
1); IR (KBr): 1717, 1585, 1340, 1242, 1195, 1141, 763, 685 cm−1; 1H NMR (400 MHz, CDCl3) δ 8.88 (d, J = 8.5 Hz, 1H), 8.32 (d, J = 8.4 Hz, 1H), 8.27 (s, 1H), 8.16 (d, J = 8.1 Hz, 1H), 8.02–7.96 (m, 2H), 7.85 (t, J = 7.6 Hz, 1H), 7.79–7.71 (m, 2H), 7.64 (t, J = 7.7 Hz, 1H), 7.54 (dt, J = 13.4, 6.6 Hz, 2H), 4.07 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 166.73, 158.97, 149.15, 137.87, 135.19, 134.05, 131.14, 130.33, 130.07, 129.55, 128.52, 127.99, 126.87, 126.13, 125.53, 124.50, 123.87, 52.76. HRMS (ESI): m/z called for C21H15NO3 [M + H]+, 314.1176; found, 314.1180.
:
1); IR (KBr): 1726, 1589, 1343, 1247, 1201, 1145, 763, 688 cm−1; 1H NMR (400 MHz, CDCl3) δ 8.85 (d, J = 8.6 Hz, 1H), 8.29 (d, J = 8.3 Hz, 1H), 8.23 (s, 1H), 8.13 (d, J = 8.2 Hz, 1H), 8.01–7.94 (m, 2H), 7.83 (s, 1H), 7.75 (d, J = 0.9 Hz, 2H), 7.65–7.60 (m, 1H), 7.53 (d, J = 1.8 Hz, 2H), 4.54 (s, 2H), 1.46 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 166.34, 158.98, 149.12, 137.94, 135.69, 134.04, 131.17, 130.32, 130.02, 129.51, 128.50, 127.94, 126.85, 126.13, 125.39, 124.30, 123.90, 61.93, 14.31. HRMS (ESI): m/z called for C21H21NO3 [M + H]+, 328.1332; found, 328.1335.
:
1); IR (KBr): 1726, 1589, 1345, 1248, 1186, 1146, 769, 682 cm−1; 1H NMR (400 MHz, CDCl3) δ 8.67 (d, J = 9.3 Hz, 1H), 8.27 (s, 1H), 8.21–8.17 (m, 2H), 7.55 (s, 3H), 7.52–7.47 (m, 1H), 7.30 (d, J = 2.7 Hz, 1H), 4.07 (s, 3H), 4.00 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 166.95, 160.85, 157.16, 151.27, 139.01, 135.33, 129.61, 128.90, 127.44, 126.52, 120.95, 119.26, 118.10, 108.10, 55.55, 52.67. HRMS (ESI): m/z called for C18H15NO3 [M + H]+, 294.1125; found, 294.1133.
:
1); IR (KBr): 1724, 1588, 1342, 1247, 1187, 1141, 765, 684 cm−1; 1H NMR (400 MHz, CDCl3) δ 8.37 (s, 1H), 8.25 (d, J = 8.5 Hz, 1H), 8.20 (d, J = 8.3 Hz, 2H), 7.51 (s, 1H), 7.10 (d, J = 7.6 Hz, 1H), 7.04 (d, J = 8.3 Hz, 2H), 4.11 (s, 3H), 4.06 (s, 3H), 3.89 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 167.08, 161.07, 155.59, 155.10, 141.29, 135.71, 131.58, 128.94, 127.54, 124.77, 120.21, 117.13, 114.27, 108.38, 56.25, 55.39, 52.69. HRMS (ESI): m/z called for C19H17NO4 [M + H]+, 323.1154; found, 323.1158.
:
1); IR (KBr): 3078, 2962, 2931, 1611, 1510, 1459 cm−1; 1H NMR (400 MHz, CDCl3) δ 9.52 (d, J = 8.0 Hz, 1H), 8.32 (d, J = 8.8 Hz, 2H), 7.91 (d, J = 4.9 Hz, 2H), 7.81 (d, J = 7.4 Hz, 4H), 7.09 (d, J = 8.8 Hz, 2H), 3.91 (s, 3H), 3.18 (s, 2H), 1.46 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 160.67, 154.90, 150.16, 146.21, 133.54, 132.75, 132.34, 128.72, 127.84, 127.53, 126.65, 125.17, 123.52, 120.95, 117.52, 114.16, 55.41, 25.84, 14.64. HRMS (ESI): m/z called for C21H21NO3 [M + H]+, 336.1594; found, 336.1589. HRMS (ESI): m/z called for C22H19NO [M + H]+, 314.1539; found, 314.1542.
:
1); IR (KBr): 3076, 2957, 2929, 1597, 1498, 1456 cm−1; 1H NMR (400 MHz, CDCl3) δ 9.55 (d, J = 8.1 Hz, 1H), 8.33 (d, J = 8.8 Hz, 2H), 7.90 (s, 2H), 7.79 (s, 4H), 7.10 (d, J = 8.8 Hz, 2H), 3.91 (s, 3H), 3.11 (s, 2H), 1.87 (d, J = 7.6 Hz, 2H), 1.09 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 160.68, 154.66, 148.71, 133.55, 132.72, 132.35, 128.73, 127.86, 127.55, 126.66, 125.18, 123.74, 121.16, 118.48, 114.16, 55.41, 34.90, 23.71, 14.20. HRMS (ESI): m/z called for C23H21NO [M + H]+, 328.1696; found, 328.1702.
:
1); IR (KBr): 3071, 2954, 2923, 1596, 1491, 1451 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.94 (s, 2H), 7.46 (s, 2H), 7.14 (d, J = 34.7 Hz, 4H), 5.92 (s, 1H), 2.38 (s, 5H), 1.55 (s, 2H), 1.33 (s, 2H), 0.87 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 188.57, 167.29, 140.31, 135.88, 135.77, 130.67, 129.71, 128.19, 126.99, 125.33, 92.55, 31.95, 30.40, 22.36, 20.94, 13.67. HRMS (ESI): m/z called for C20H21N [M + H]+, 276.1713; found, 276.1716.
:
1); IR (KBr): 3078, 2961, 2929, 1563, 1498, 1457 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.99 (s, 2H), 7.47 (d, J = 6.1 Hz, 2H), 6.91 (s, 1H), 6.85 (s, 2H), 5.95 (s, 1H), 2.47 (s, 2H), 2.36 (s, 6H), 1.60 (s, 2H), 1.38 (s, 2H), 0.91 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 188.50, 167.03, 140.37, 138.81, 138.31, 130.69, 128.21, 127.64, 127.03, 122.89, 92.70, 31.97, 30.47, 22.38, 21.24, 13.69. HRMS (ESI): m/z called for C21H23N [M + H]+, 290.1817; found, 290.1819.
:
1); IR (KBr): 3075, 2959, 2928, 1599, 1495, 1453 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.95 (d, J = 6.5 Hz, 2H), 7.47 (s, 2H), 7.20 (d, J = 7.8 Hz, 2H), 7.09 (d, J = 7.8 Hz, 2H), 5.92 (s, 1H), 2.39 (s, 5H), 1.56 (s, 2H), 1.28 (s, 4H), 0.86 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 188.57, 167.32, 140.32, 135.89, 135.78, 130.67, 129.72, 128.19, 126.99, 125.33, 92.54, 32.21, 31.39, 27.93, 22.19, 20.94, 13.81. HRMS (ESI): m/z called for C21H23N [M + H]+, 290.1817; found, 290.1819.
:
1); IR (KBr): 3078, 2962, 2931, 1591, 1484, 1447 cm−1; 1H NMR (400 MHz, CDCl3) δ 9.37 (d, J = 7.4 Hz, 1H), 7.89 (s, 2H), 7.82 (s, 1H), 7.71–7.63 (m, 4H), 7.05 (d, J = 8.6 Hz, 2H), 3.91 (s, 3H), 3.27 (s, 2H), 2.91 (s, 2H), 2.02 (s, 2H), 1.80 (s, 2H). 13C NMR (101 MHz, CDCl3) δ 159.54, 142.11, 132.99, 130.85, 129.04, 127.43, 127.41, 126.91, 126.60, 124.94, 120.53, 113.46, 55.38, 29.13, 26.20, 22.89, 22.55. HRMS (ESI): m/z called for C24H21NO [M + H]+, 340.1696; found, 340.1708.
:
1); IR (KBr): 3070, 2951, 2922, 1592, 1491, 1453 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.96 (dd, J = 7.5, 1.7 Hz, 2H), 7.46 (s, 2H), 7.16 (d, J = 4.8 Hz, 2H), 7.08 (s, 2H), 5.95 (s, 1H), 2.37 (s, 2H), 1.52 (s, 2H), 1.32 (s, 2H), 0.86 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 188.92, 167.07, 162.06, 159.61, 140.10, 134.50, 134.47, 130.86, 128.25, 127.38, 127.30, 127.04, 116.10, 92.83, 31.90, 30.34, 22.34, 13.63. HRMS (ESI): m/z called for C19H18FN [M + H]+, 280.1455; found, 280.1457.
:
1); IR (KBr): 3071, 2953, 2924, 1593, 1491, 1452 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.97 (d, J = 1.3 Hz, 2H), 7.47 (s, 2H), 7.36 (s, 2H), 7.13 (s, 2H), 5.97 (s, 1H), 2.41 (s, 2H), 1.53 (s, 2H), 1.34 (s, 2H), 0.87 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 189.04, 166.39, 139.99, 137.17, 131.43, 130.98, 129.30, 128.28, 127.07, 126.42, 93.37, 31.96, 30.33, 22.35, 13.68. HRMS (ESI): m/z called for C19H18ClN [M + H]+, 296.1107; found, 296.1109.
:
1); IR (KBr): 3073, 2954, 2925, 1597, 1495, 1451 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.94 (dd, J = 7.9, 1.6 Hz, 2H), 7.50 (s, 4H), 7.09 (s, 2H), 5.96 (s, 1H), 2.42 (d, J = 8.0 Hz, 2H), 1.53 (d, J = 7.5 Hz, 2H), 1.34 (d, J = 7.5 Hz, 2H), 0.88 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 189.12, 166.30, 139.96, 137.68, 132.28, 130.98, 128.28, 127.05, 126.74, 119.23, 93.45, 31.97, 30.34, 22.35, 13.67. HRMS (ESI): m/z called for C19H18BrN [M + H]+, 340.0696; found, 340.0693.
:
1); IR (KBr): 3075, 2959, 2928, 1599, 1495, 1453 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.98–7.90 (m, 2H), 7.71 (d, J = 8.5 Hz, 2H), 7.47 (s, 2H), 6.97 (s, 2H), 5.96 (s, 1H), 2.44 (s, 2H), 1.55 (s, 2H), 1.35 (d, J = 7.5 Hz, 2H), 0.89 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 189.13, 166.17, 139.95, 138.39, 138.24, 130.99, 128.27, 127.05, 126.90, 93.55, 90.04, 31.98, 30.34, 22.35, 13.67. HRMS (ESI): m/z called for C19H18IN [M + H]+, 388.0533; found, 388.0537.
:
1); IR (KBr): 3055, 3028, 2920, 1589, 1546, 1488, 1444 cm−1; 1H NMR (400 MHz, CDCl3) δ 8.29 (d, J = 8.4 Hz, 1H), 8.23 (d, J = 7.3 Hz, 2H), 7.93 (d, J = 8.3 Hz, 1H), 7.85 (s, 1H), 7.75 (s, 1H), 7.58 (d, J = 1.7 Hz, 7H), 7.51–7.46 (m, 2H). 13C NMR (101 MHz, CDCl3) δ 156.87, 149.15, 148.83, 139.66, 138.41, 130.14, 129.55, 129.49, 129.32, 128.81, 128.58, 128.38, 127.58, 126.31, 125.77, 125.62, 119.33. HRMS (ESI): m/z called for C21H15N [M + H]+, 282.1277; found, 282.1279.
:
1); IR (KBr): 3054, 2915, 1588, 1544, 1488, 1449 cm−1; 1H NMR (400 MHz, CDCl3) δ 8.26 (s, 1H), 7.99 (s, 2H), 7.71 (s, 1H), 7.41 (s, 6H), 6.94 (s, 2H), 6.72 (d, J = 7.5 Hz, 2H), 6.09 (s, 1H), 2.26 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 189.40, 161.72, 139.95, 136.78, 135.90, 134.10, 133.85, 133.05, 131.17, 130.78, 129.56, 129.29, 128.48, 128.32, 127.20, 123.19, 96.54, 20.76. HRMS (ESI): m/z called for C22H17N [M + H]+, 296.1443; found, 295.1445.
:
1); IR (KBr): 3052, 2913, 1586, 1542, 1487, 1448 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.82 (d, J = 9.1 Hz, 1H), 7.66 (s, 1H), 7.18 (d, J = 2.6 Hz, 1H), 6.91 (d, J = 2.4 Hz, 1H), 3.80 (s, 3H), 2.83 (s, 2H), 2.71 (s, 2H), 1.74 (s, 2H), 1.23 (s, 3H), 0.97 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 158.32, 156.13, 141.50, 134.59, 131.87, 128.91, 127.14, 119.73, 103.68, 54.41, 36.54, 24.17, 21.87, 13.45, 13.31.Footnote |
| † Electronic supplementary information (ESI) available. See DOI: 10.1039/c7ra00870h |
| This journal is © The Royal Society of Chemistry 2017 |